aTyr Pharma | LIFE - Market Capitalization


aTyr Pharma reported $408.5M in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Alterity Therapeutics Limited AUD 39M 17M Sep/2026
Ardelyx USD 718M 542M Nov/2026
aTyr Pharma USD 359M 351M Nov/2026
Biogen USD 33.38B 1.48B Sep/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Cipla INR 1.09T 96.42B Sep/2026
Clal Biotechnology ILS 52.36M 2.09M Mar/2025
Compugen USD 564.53M 41.47M Nov/2026
CSL USD 55.89B 20.42B Dec/2025
Curis USD 22M 9M Mar/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Lakefront Biotherapeutics EUR 1.73B 2.64M Jun/2026
Novartis USD 292.09B 51.5B Sep/2026
Roche Holding CHF 270B 3.66B Jun/2026
United Therapeutics USD 28.64B 5.4B Nov/2026